"Recurrence" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The return of a sign, symptom, or disease after a remission.
| Descriptor ID |
D012008
|
| MeSH Number(s) |
C23.550.291.937
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Recurrence".
Below are MeSH descriptors whose meaning is more specific than "Recurrence".
This graph shows the total number of publications written about "Recurrence" by people in this website by year, and whether "Recurrence" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 10 | 10 |
| 1997 | 0 | 15 | 15 |
| 1998 | 0 | 20 | 20 |
| 1999 | 0 | 16 | 16 |
| 2000 | 0 | 11 | 11 |
| 2001 | 0 | 14 | 14 |
| 2002 | 0 | 21 | 21 |
| 2003 | 0 | 24 | 24 |
| 2004 | 0 | 27 | 27 |
| 2005 | 0 | 17 | 17 |
| 2006 | 0 | 31 | 31 |
| 2007 | 0 | 30 | 30 |
| 2008 | 0 | 30 | 30 |
| 2009 | 0 | 21 | 21 |
| 2010 | 0 | 35 | 35 |
| 2011 | 0 | 40 | 40 |
| 2012 | 0 | 27 | 27 |
| 2013 | 0 | 43 | 43 |
| 2014 | 0 | 38 | 38 |
| 2015 | 0 | 41 | 41 |
| 2016 | 0 | 39 | 39 |
| 2017 | 0 | 46 | 46 |
| 2018 | 0 | 51 | 51 |
| 2019 | 0 | 51 | 51 |
| 2020 | 0 | 45 | 45 |
| 2021 | 0 | 40 | 40 |
| 2022 | 0 | 26 | 26 |
| 2023 | 0 | 33 | 33 |
| 2024 | 13 | 14 | 27 |
| 2025 | 0 | 32 | 32 |
| 2026 | 0 | 29 | 29 |
To return to the timeline,
click here.
Below are the most recent publications written about "Recurrence" by people in Profiles.
-
INSPPIRE: Advances in the Understanding of Pediatric Pancreatitis. Pancreas. 2026 Sep 01; 55(8):e888-e894.
-
Engraftment across major ABO blood group and rhesus E antigen incompatibility in the presence of persistent anti-E antibodies and late serologic findings coinciding with disease relapse. BMJ Case Rep. 2026 Aug 06; 19(8).
-
Exploratory identification of candidate SNP markers associated with recurrent clinical mastitis in Holstein cattle. PLoS One. 2026; 21(7):e0355230.
-
Recurrent Hypoglycemia Following Asparaginase Therapy for Lymphoid Malignancies in Childhood: The Texas Children's Hospital Experience. Pediatr Blood Cancer. 2026 Sep; 73(9):e70457.
-
Clofarabine for relapsed/refractory LCH and non-LC histiocytosis. Blood Adv. 2026 07 28; 10(14):5087-5096.
-
Effect of Left Atrial Size and Volume Reduction on Pulmonary Vein Isolation Efficacy in Patients With Persistent and Longstanding Persistent Atrial Fibrillation: Subset Analysis From the aMAZE Trial. Circ Arrhythm Electrophysiol. 2026 Aug; 19(8):e014755.
-
FcRH5?CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial. Nat Med. 2026 Aug; 32(8):2909-2917.
-
Disease extent, not lesion location, determines relapse risk in single-system skeletal Langerhans cell histiocytosis. Blood Adv. 2026 07 14; 10(13):4776-4785.
-
Comparative effectiveness of chimeric antigen receptor (CAR) T-cell therapy versus historical controls in patients with relapse/refractory aggressive B-cell lymphoma: An indirect treatment comparison in the real-world setting. Br J Haematol. 2026 Sep; 209(3):1230-1238.
-
Donor Selection and Human Leukocyte Antigen Loss Leukemia Relapse After Hematopoietic Cell Transplantation. J Clin Oncol. 2026 Aug 10; 44(23):2221-2232.